Hammerco Lawyers has filed a class action lawsuit on behalf of Canadian residents in light of Health Canada’s drug recall advisory on March 9.
Multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA).
NMBA is potentially a human carcinogen, which means that long-term exposure could increase the potential risk of cancer.
Please contact Kevin McLaren if you think you may have been affected by the Losartan drug recall.
More News & Resources
June 1, 2026
If you’ve been left out of a will in British Columbia, you may have legal options, but they depend on your relationship to the deceased and the specific facts of your situation.
May 19, 2026
In Ahluwalia v. Ahluwalia, 2026 SCC 16, the Supreme Court of Canada recognized a new tort of intimate partner violence. This development extends the law to allow survivors to bring claims against their romantic...
May 12, 2026
Hammerco Lawyers LLP has released Still Rising: Navigating Your Legal Options After Sexual Assault, a free resource designed to support survivors of sexual violence and those who work with them.